Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
363 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
General Oncology, Inc.Pharmaceuticals
Brookline, Massachusetts · Equity · 43 investors · Michael Petit, Arnold Glazier
Sparrow Pharmaceuticals, Inc.Pharmaceuticals
Portland, Oregon · Equity · 17 investors · Jonathan Root, Niall O'Donnell
Acurx Pharmaceuticals, Inc.Pharmaceuticals
Staten Island, New York · Options, Convertible · 1 investors · Robert Shawah, James Donohue
Shuttle Pharmaceuticals Holdings, Inc.Pharmaceuticals
Gaithersburg, Maryland · Equity, Options, Convertible · 1 investors · Mira Jung, Tyvin Rich
Arthrosi Therapeutics, Inc.Pharmaceuticals
Laguna Hills, California · Equity · 13 investors · Zhang Mingyuan, Chaohua Yuan
Indaptus Therapeutics, Inc.Pharmaceuticals
New York, New York · founded 2021 · Options, Convertible · 20 investors · Anthony Maddaluna, Hila Karah
Lumina Pharmaceuticals Inc.Pharmaceuticals
Boston, Massachusetts · founded 2025 · Simple Agreement for Future Equity · 2 investors · Alma Sorensen, Peter Caravan
AltrixBio, Inc.Pharmaceuticals
Lowell, Massachusetts · Equity · 20 investors · John Brooks, Jeffrey Karp
AltrixBio, Inc.Pharmaceuticals
Wilmington, Delaware · Convertible Debt · 50 investors · Jeffrey Karp, Nancy Briefs
AltrixBio, Inc.Pharmaceuticals
Lowell, Massachusetts · Convertible Debt · 20 investors · Ali Tavakkoli, John Brooks
Maxona Pharmaceuticals, Inc.Pharmaceuticals
Malvern, Pennsylvania · Equity · 15 investors · David Nakamura, Shahin Fatholahi
Pharmazz, Inc.Pharmaceuticals
Willowbrook, Illinois · Equity, Options · 1 investors · David Costello, Sunil Gulati
Etheros Pharmaceuticals Corp.Pharmaceuticals
Nashville, Tennessee · founded 2022 · Simple agreement for future equity (SAFE) · 6 investors · Subhasish Chakraborty, John Scannell
Duo Oncology Inc.Pharmaceuticals
Pittsburgh, Pennsylvania · founded 2020 · Debt, Options, Convertible · 8 investors · Lusong Luo, Jingjing Sun
Cristcot LLCPharmaceuticals
Concord, Massachusetts · Equity · 3 investors · Marc Keller, Ernest Pomerantz
Fedora Pharmaceuticals Inc.Pharmaceuticals
Edmonton, Alberta, Canada · Equity, "Class ""B"" Voting Common Shares" · 10 investors · Sarat Maharaj, Christopher Micetich
ASCENDIA PHARMACEUTICALS, INC.Pharmaceuticals
New Brunswick, New Jersey · founded 2021 · Equity · 9 investors · Shoufeng Li, James Gale
Macrotope, Inc.Pharmaceuticals
Princeton, New Jersey · Debt · 1 investors · Elliot Camptbell, Stephen Anderson
Pagari Life Science Corp.Pharmaceuticals
Bethalta, Illinois · founded 2022 · Equity · 6 investors · Stephen Peipert, James Wickenhauser
Jaguar Health, Inc.Pharmaceuticals
San Francisco, California · Options · 3 investors · Carol Lizak, Pravin Chaturvedi
Branch Therapeutics, Inc.Pharmaceuticals
Houston, Texas · founded 2024 · Equity · 1 investors · Sourav Banerjee, Curtis Thorne
Crosslink Therapeutics Inc.Pharmaceuticals
Boston, Massachusetts · founded 2021 · Options, Convertible · 6 investors · Ronald Seidel, III, Cameron Gallagher
ADIAL PHARMACEUTICALS, INC.Pharmaceuticals
Glen Allen, Virginia · Options, Convertible · 1 investors · Vinay Shah, James Newman, Jr.
Pneuma Respiratory, Inc.Pharmaceuticals
Boone, North Carolina · Debt, Convertible Notes · 25 investors · Douglas Stoner, Farrukh Hameed
Sentonix, Inc.Pharmaceuticals
Arlington, Massachusetts · founded 2023 · Debt · 15 investors · Karl Schmidt, John Beaver
Sentonix, Inc.Pharmaceuticals
Arlington, Massachusetts · founded 2023 · Debt · 15 investors · Karl Schmidt, John Beaver
Niche Biopharmaceuticals LLCPharmaceuticals
Shorewood, Minnesota · founded 2020 · Equity · 2 investors · Paul Brennan, Robert Klem
Retension Pharmaceuticals, Inc.Pharmaceuticals
Mclean, Virginia · founded 2023 · Equity · 98 investors · Eric Keller, Michael Berendt
CERO THERAPEUTICS HOLDINGS, INC.Pharmaceuticals
South San Francisco, California · founded 2021 · Equity · 5 investors · Shami Patel, Kristen Pierce
Mind Medicine (MindMed) Inc.Pharmaceuticals
New York, New York · Equity, Term loan, $7,000,000 of which is convertible into common shares. · 1 investors · Carrie Liao, Suzanne Bruhn